glipizide has been researched along with Dyslipidemia in 1 studies
Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mu, J | 1 |
| Woods, J | 1 |
| Zhou, YP | 1 |
| Roy, RS | 1 |
| Li, Z | 1 |
| Zycband, E | 1 |
| Feng, Y | 1 |
| Zhu, L | 1 |
| Li, C | 1 |
| Howard, AD | 1 |
| Moller, DE | 1 |
| Thornberry, NA | 1 |
| Zhang, BB | 1 |
1 other study available for glipizide and Dyslipidemia
| Article | Year |
|---|---|
Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; | 2006 |